Table 2.
Patient’s condition upon admission of severe COVID-19 pneumonia patients admitted to Jimma University Medical Center, Jimma, Oromia, Ethiopia
| Variable | Category | Frequency | Percent |
|---|---|---|---|
| Blood pressure | Normal (90/60–120/80 mmHg) | 91 | 40.6 |
| Elevated (130/90–140/90 mmHg) | 67 | 29.9 | |
| Hypertension (> 140/90 mmHg) | 60 | 26.8 | |
| Hypotension (< 90/60 mmHg) | 6 | 2.7 | |
| Pulse rate | Normal (60–100 beats per minute) | 143 | 63.8 |
| Bradycardia (< 60 beats per minute) | 2 | 0.9 | |
| Tachycardia (> 100 beats per minute) | 79 | 35.3 | |
| Respiratory rate | Normal (12–20 breaths per minute) | 6 | 2.7 |
| Tachypnea (> 20 breaths per minute) | 218 | 97.3 | |
| Temperature (°C) | Normal (35.5–37.5) | 150 | 67 |
| Febrile (> 37.5) | 74 | 33 | |
| Oxygen saturation (SPO 2 ) | Normal (> 93%) | 34 | 15.2 |
| Hypoxemia (< 93%) | 190 | 84.8 | |
| GCS | Normal (15/15) | 132 | 58.9 |
| Lethargic (13–14/15) | 66 | 29.5 | |
| Stuporous (8–12/15) | 26 | 11.6 | |
| Comorbidity | Yes | 141 | 62.9 |
| No | 83 | 37.1 | |
| Types of Comorbidities | Diabetes | 47 | 21 |
| HIV | 9 | 4 | |
| Hypertension | 60 | 26.8 | |
| Heart failure | 68 | 30.4 | |
| Previous nephrotoxic drug use | NSAID | 12 | 5.4 |
| ACEI | 33 | 14.7 | |
| Othera | 5 | 2.2 | |
| Onset of symptoms in days | < 4 | 51 | 22.8 |
| 4–5 | 85 | 37.9 | |
| 5–7 | 66 | 29.5 | |
| > 7 | 22 | 9.8 |
GCS Glasgow coma scale, HIV human immuno-deficiency virus, NSAID nonsteroidal anti-inflammatory drug, ACEI angiotensin-converting enzyme inhibitor
aAminoglycoside, Chemotherapy